Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: risk, outcome, vaccination and beyond, volume II
Main Authors: | Aikaterini Patsatsi, Maryam Daneshpazhooh, Soheil Tavakolpour, Hamidreza Mahmoudi, Dedee F. Murrell |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1268285/full |
Similar Items
-
Editorial: Challenges of COVID-19 in dermatology patients on immunosuppression: Risk, outcome, vaccination, and beyond
by: Hamidreza Mahmoudi, et al.
Published: (2022-08-01) -
Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients
by: Nika Kianfar, et al.
Published: (2022-02-01) -
Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
by: Nika Kianfar, et al.
Published: (2022-07-01) -
The Intriguing Links between Psoriasis and Bullous Pemphigoid
by: Carlo Alberto Maronese, et al.
Published: (2022-12-01) -
Vitamin D status in patients with autoimmune bullous dermatoses: a meta-analysis
by: Miao Yang, et al.
Published: (2022-04-01)